1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$680,622UH3FY2022HLNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Mark Thomas Gladwincontact Darrell J Triulzi

Linked publications & trials

Paper 39478346 Paper 38746469 Paper 38559268 Paper 38400625 Paper 37439373 Paper 36763969 Paper 35549664 Paper 35384045 Paper 34516300

View original record on NIH RePORTER →